A new model for gonorrhea control in Canada: Surveillance, new way of selecting best therapeutics and maybe a vaccine?

Gonorrhea resistance surveillance is of utmost importance as it allows for rapid treatment guidelines adjustments. The advent of rapid testing tools can help best select antibiotic choice thus decreasing the selective pressure on a single antibiotic. Data emerging about vaccine giving protection against gonorrhea makes us think that we may have a new tool in a near future to help gonorrhea control. This webinar will be presented in English. This webinar will be recorded.

Webinar Speakers

• Helen Marshall, MBBS, MD, MPH (Medical Director VIRTU & A-Prof Vaccinology, Affiliate Lecturer @University of Adelaide, Adelaide Medical School)
• Jo-Anne Dillon PhD, FCAHS FRSC (Professor Biochemistry, Microbiology & Immunology @University of Saskatchewan)
• Irene Martin (Head, Streptococcus and STI Unit @National Microbiology Laboratory, Public Health Agency of Canada)
• Marc Steben, M.D. (Président | President | Moderator @IUSTI – l’UIIT Canada)